US Patent 11440914 Tricyclic amine compounds as CDK2 inhibitors
Patent 11440914 was granted and assigned to Incyte on September, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Jul, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114409140
Date of Patent
September 13, 2022
0Patent Application Number
168637700
Date Filed
April 30, 2020
0Patent Citations
Patent Primary Examiner
Edits on 26 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 21 Apr, 2023
Golden AI
Infobox
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114409140
Date of Patent
September 13, 2022
0Patent Application Number
168637700
Date Filed
April 30, 2020
0Patent Citations
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114409140
Date of Patent
September 13, 2022
0Patent Application Number
168637700
Date Filed
April 30, 2020
0Patent Citations
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Edits on 19 Sep, 2022
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+212 characters)
US Patent 11440914 Tricyclic amine compounds as CDK2 inhibitors
Article
The present application provides tricyclic amine compounds, which are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114409140
Date of Patent
September 13, 2022
0Patent Application Number
168637700
Date Filed
April 30, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11440914 Tricyclic amine compounds as CDK2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
